Get the Stockscreener App
120.67
0.62%
0.74
Illumina Inc stock is traded at $120.67, with a volume of 1.06M.
It is up +0.62% in the last 24 hours and up +32.60% over the past month.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
See More
Previous Close:
$119.93
Open:
$117.32
24h Volume:
1.06M
Relative Volume:
0.64
Market Cap:
$18.55B
Revenue:
$4.28B
Net Income/Loss:
$1.26B
P/E Ratio:
15.28
EPS:
7.8957
Net Cash Flow:
$943.00M
1W Performance:
-1.01%
1M Performance:
+32.60%
6M Performance:
+54.29%
1Y Performance:
-15.16%
1-Day Range:
$117.10
$121.50
1-Week Range:
$117.10
$125.50
52-Week Range:
$68.70
$153.06
Illumina Inc Stock (ILMN) Company Profile
Name
Illumina Inc
Sector
Industry
Phone
(858) 202-4500
Address
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
120.67 | 18.33B | 4.28B | 1.26B | 943.00M | 7.8957 |
|
TMO
Thermo Fisher Scientific Inc
|
578.71 | 217.96B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
221.21 | 156.24B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
689.93 | 56.01B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.82 | 41.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
220.61 | 38.07B | 15.90B | 1.28B | 2.21B | 7.2842 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Jul-11-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-04-25 | Reiterated | Citigroup | Neutral |
| Feb-28-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-10-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Feb-07-25 | Downgrade | TD Cowen | Buy → Hold |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Nov-12-24 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Aug-28-24 | Upgrade | Argus | Hold → Buy |
| Aug-16-24 | Upgrade | Daiwa Securities | Neutral → Buy |
| Aug-14-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-14-24 | Upgrade | TD Cowen | Hold → Buy |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Dec-18-23 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Dec-15-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-11-23 | Upgrade | Citigroup | Sell → Neutral |
| Nov-10-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-28-23 | Initiated | Bernstein | Underperform |
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-25-23 | Downgrade | Argus | Buy → Hold |
| Jan-05-23 | Initiated | Scotiabank | Sector Perform |
| Dec-12-22 | Downgrade | Citigroup | Neutral → Sell |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-04-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Sep-28-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-13-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-18-22 | Upgrade | Stifel | Hold → Buy |
| Jan-11-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-07-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Mar-31-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Mar-31-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Underweight |
| Dec-22-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-17-20 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-22-20 | Downgrade | Stifel | Buy → Hold |
| Sep-22-20 | Downgrade | UBS | Buy → Neutral |
| Sep-21-20 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-07-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Aug-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-24-20 | Downgrade | Citigroup | Buy → Neutral |
| Apr-21-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-15-19 | Initiated | Stifel | Buy |
| Oct-25-19 | Initiated | Guggenheim | Buy |
View All
Illumina Inc Stock (ILMN) Latest News
Will Illumina Inc. (ILU) stock keep high P E multiplesJuly 2025 Patterns & Community Supported Trade Ideas - newser.com
Why The Narrative Around Illumina Is Shifting After Recent Analyst Upgrades and Sector Changes - Yahoo Finance
Why analysts maintain buy rating on Illumina Inc. (ILU) stockJuly 2025 Closing Moves & Safe Entry Point Identification - newser.com
Published on: 2025-11-16 02:07:39 - newser.com
Published on: 2025-11-16 02:04:01 - newser.com
What moving averages say about Illumina Inc.July 2025 Final Week & Low Drawdown Trading Strategies - newser.com
Is Illumina Inc. stock a buy in volatile marketsIPO Watch & Free Fast Gain Swing Trade Alerts - newser.com
Strategies to average down on Illumina Inc.July 2025 Review & Reliable Momentum Entry Alerts - newser.com
Analyzing Illumina Inc. with risk reward ratio charts2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com
Illumina Inc Stock Analysis and ForecastVolatility Trading Techniques & Fast Profit Stock Ideas - earlytimes.in
Real time pattern detection on Illumina Inc. stockQuarterly Profit Review & Proven Capital Preservation Tips - newser.com
Is Illumina Inc. forming a bottoming baseJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - newser.com
Is Illumina Inc. (ILU) stock a buy on weaknessPortfolio Performance Report & Accurate Buy Signal Alerts - newser.com
Is Illumina Inc. (ILU) stock inflation resilient2025 Support & Resistance & Daily Profit Maximizing Trade Tips - newser.com
Will Illumina Inc. stock benefit from automationJuly 2025 Rallies & Low Drawdown Trading Strategies - newser.com
Illumina’s Market Dominance Faces New Test As Roche Plans 2026 Sequencer Launch - Citeline News & Insights
Published on: 2025-11-13 22:27:47 - newser.com
Key facts: Illumina to Issue $500M Notes; Officer Files to Sell Shares - TradingView
Illumina: Will Its Latest China Partnerships Unlock Its Next Billion-Dollar Market? - Smartkarma
Combining machine learning predictions for Illumina Inc.Recession Risk & Weekly Momentum Stock Picks - newser.com
What Nebraska knows about better precision oncology - Illumina
Momentum divergence signals in Illumina Inc. chartPortfolio Return Report & Growth-Oriented Investment Plans - newser.com
Will Illumina Inc. (ILU) stock draw ESG focused fundsQuarterly Performance Summary & Precise Swing Trade Alerts - newser.com
Illumina, Inc. (ILU.DE) stock price, news, quote and history - Yahoo Finance UK
Published on: 2025-11-12 23:20:26 - newser.com
Illumina Announces $500M Notes Issuance Agreement - TipRanks
Illumina study shows whole-genome sequencing solves missing heritability By Investing.com - Investing.com Canada
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study - PR Newswire
Illumina Inc files for offering of $500 million 4.750% notes due 2030 - MarketScreener
Illumina Inc Files For Offering Of $500 Million 4.750% Notes Due 2030 - TradingView
Illumina, Inc. (ILMN) Stock Forecasts - Yahoo Finance
Illumina To Webcast Upcoming Investor Conference - PR Newswire
Illumina protein prep solution adopted by over 40 customers globally - Investing.com Nigeria
China to lift export ban on Illumina - Medical Buyer
Why Illumina Inc. (ILU) stock benefits from AI revolutionJuly 2025 Patterns & Fast Entry High Yield Tips - newser.com
Chinese to lift export ban on Illumina - Medical Buyer
How China’s Easing of the Export Ban Has Changed Illumina’s (ILMN) Investment Story - simplywall.st
Illumina Inc Stock (ILMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):